Shikimic Acid Production in Escherichia coli: From Classical Metabolic Engineering Strategies to Omics Applied to Improve Its Production.
Identifieur interne : 000D06 ( Main/Exploration ); précédent : 000D05; suivant : 000D07Shikimic Acid Production in Escherichia coli: From Classical Metabolic Engineering Strategies to Omics Applied to Improve Its Production.
Auteurs : Juan Andrés Martínez [Mexique] ; Francisco Bolívar [Mexique] ; Adelfo Escalante [Mexique]Source :
- Frontiers in bioengineering and biotechnology [ 2296-4185 ] ; 2015.
Abstract
Shikimic acid (SA) is an intermediate of the SA pathway that is present in bacteria and plants. SA has gained great interest because it is a precursor in the synthesis of the drug oseltamivir phosphate (OSF), an efficient inhibitor of the neuraminidase enzyme of diverse seasonal influenza viruses, the avian influenza virus H5N1, and the human influenza virus H1N1. For the purposes of OSF production, SA is extracted from the pods of Chinese star anise plants (Illicium spp.), yielding up to 17% of SA (dry basis content). The high demand for OSF necessary to manage a major influenza outbreak is not adequately met by industrial production using SA from plants sources. As the SA pathway is present in the model bacteria Escherichia coli, several "intuitive" metabolically engineered strains have been applied for its successful overproduction by biotechnological processes, resulting in strains producing up to 71 g/L of SA, with high conversion yields of up to 0.42 (mol SA/mol Glc), in both batch and fed-batch cultures using complex fermentation broths, including glucose as a carbon source and yeast extract. Global transcriptomic analyses have been performed in SA-producing strains, resulting in the identification of possible key target genes for the design of a rational strain improvement strategy. Because possible target genes are involved in the transport, catabolism, and interconversion of different carbon sources and metabolic intermediates outside the central carbon metabolism and SA pathways, as genes involved in diverse cellular stress responses, the development of rational cellular strain improvement strategies based on omics data constitutes a challenging task to improve SA production in currently overproducing engineered strains. In this review, we discuss the main metabolic engineering strategies that have been applied for the development of efficient SA-producing strains, as the perspective of omics analysis has focused on further strain improvement for the production of this valuable aromatic intermediate.
DOI: 10.3389/fbioe.2015.00145
PubMed: 26442259
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000396
- to stream PubMed, to step Curation: 000395
- to stream PubMed, to step Checkpoint: 000395
- to stream Ncbi, to step Merge: 000751
- to stream Ncbi, to step Curation: 000751
- to stream Ncbi, to step Checkpoint: 000751
- to stream Main, to step Merge: 000D07
- to stream Main, to step Curation: 000D06
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Shikimic Acid Production in Escherichia coli: From Classical Metabolic Engineering Strategies to Omics Applied to Improve Its Production.</title>
<author><name sortKey="Martinez, Juan Andres" sort="Martinez, Juan Andres" uniqKey="Martinez J" first="Juan Andrés" last="Martínez">Juan Andrés Martínez</name>
<affiliation wicri:level="1"><nlm:affiliation>Departamento de Ingeniería Celular y Biocatálisis, Instituto de Biotecnología, Universidad Nacional Autónoma de México , Cuernavaca , Mexico.</nlm:affiliation>
<country xml:lang="fr">Mexique</country>
<wicri:regionArea>Departamento de Ingeniería Celular y Biocatálisis, Instituto de Biotecnología, Universidad Nacional Autónoma de México , Cuernavaca </wicri:regionArea>
<wicri:noRegion>Cuernavaca </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bolivar, Francisco" sort="Bolivar, Francisco" uniqKey="Bolivar F" first="Francisco" last="Bolívar">Francisco Bolívar</name>
<affiliation wicri:level="1"><nlm:affiliation>Departamento de Ingeniería Celular y Biocatálisis, Instituto de Biotecnología, Universidad Nacional Autónoma de México , Cuernavaca , Mexico.</nlm:affiliation>
<country xml:lang="fr">Mexique</country>
<wicri:regionArea>Departamento de Ingeniería Celular y Biocatálisis, Instituto de Biotecnología, Universidad Nacional Autónoma de México , Cuernavaca </wicri:regionArea>
<wicri:noRegion>Cuernavaca </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Escalante, Adelfo" sort="Escalante, Adelfo" uniqKey="Escalante A" first="Adelfo" last="Escalante">Adelfo Escalante</name>
<affiliation wicri:level="1"><nlm:affiliation>Departamento de Ingeniería Celular y Biocatálisis, Instituto de Biotecnología, Universidad Nacional Autónoma de México , Cuernavaca , Mexico.</nlm:affiliation>
<country xml:lang="fr">Mexique</country>
<wicri:regionArea>Departamento de Ingeniería Celular y Biocatálisis, Instituto de Biotecnología, Universidad Nacional Autónoma de México , Cuernavaca </wicri:regionArea>
<wicri:noRegion>Cuernavaca </wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:26442259</idno>
<idno type="pmid">26442259</idno>
<idno type="doi">10.3389/fbioe.2015.00145</idno>
<idno type="wicri:Area/PubMed/Corpus">000396</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000396</idno>
<idno type="wicri:Area/PubMed/Curation">000395</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000395</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000395</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000395</idno>
<idno type="wicri:Area/Ncbi/Merge">000751</idno>
<idno type="wicri:Area/Ncbi/Curation">000751</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000751</idno>
<idno type="wicri:doubleKey">2296-4185:2015:Martinez J:shikimic:acid:production</idno>
<idno type="wicri:Area/Main/Merge">000D07</idno>
<idno type="wicri:Area/Main/Curation">000D06</idno>
<idno type="wicri:Area/Main/Exploration">000D06</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Shikimic Acid Production in Escherichia coli: From Classical Metabolic Engineering Strategies to Omics Applied to Improve Its Production.</title>
<author><name sortKey="Martinez, Juan Andres" sort="Martinez, Juan Andres" uniqKey="Martinez J" first="Juan Andrés" last="Martínez">Juan Andrés Martínez</name>
<affiliation wicri:level="1"><nlm:affiliation>Departamento de Ingeniería Celular y Biocatálisis, Instituto de Biotecnología, Universidad Nacional Autónoma de México , Cuernavaca , Mexico.</nlm:affiliation>
<country xml:lang="fr">Mexique</country>
<wicri:regionArea>Departamento de Ingeniería Celular y Biocatálisis, Instituto de Biotecnología, Universidad Nacional Autónoma de México , Cuernavaca </wicri:regionArea>
<wicri:noRegion>Cuernavaca </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bolivar, Francisco" sort="Bolivar, Francisco" uniqKey="Bolivar F" first="Francisco" last="Bolívar">Francisco Bolívar</name>
<affiliation wicri:level="1"><nlm:affiliation>Departamento de Ingeniería Celular y Biocatálisis, Instituto de Biotecnología, Universidad Nacional Autónoma de México , Cuernavaca , Mexico.</nlm:affiliation>
<country xml:lang="fr">Mexique</country>
<wicri:regionArea>Departamento de Ingeniería Celular y Biocatálisis, Instituto de Biotecnología, Universidad Nacional Autónoma de México , Cuernavaca </wicri:regionArea>
<wicri:noRegion>Cuernavaca </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Escalante, Adelfo" sort="Escalante, Adelfo" uniqKey="Escalante A" first="Adelfo" last="Escalante">Adelfo Escalante</name>
<affiliation wicri:level="1"><nlm:affiliation>Departamento de Ingeniería Celular y Biocatálisis, Instituto de Biotecnología, Universidad Nacional Autónoma de México , Cuernavaca , Mexico.</nlm:affiliation>
<country xml:lang="fr">Mexique</country>
<wicri:regionArea>Departamento de Ingeniería Celular y Biocatálisis, Instituto de Biotecnología, Universidad Nacional Autónoma de México , Cuernavaca </wicri:regionArea>
<wicri:noRegion>Cuernavaca </wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Frontiers in bioengineering and biotechnology</title>
<idno type="ISSN">2296-4185</idno>
<imprint><date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Shikimic acid (SA) is an intermediate of the SA pathway that is present in bacteria and plants. SA has gained great interest because it is a precursor in the synthesis of the drug oseltamivir phosphate (OSF), an efficient inhibitor of the neuraminidase enzyme of diverse seasonal influenza viruses, the avian influenza virus H5N1, and the human influenza virus H1N1. For the purposes of OSF production, SA is extracted from the pods of Chinese star anise plants (Illicium spp.), yielding up to 17% of SA (dry basis content). The high demand for OSF necessary to manage a major influenza outbreak is not adequately met by industrial production using SA from plants sources. As the SA pathway is present in the model bacteria Escherichia coli, several "intuitive" metabolically engineered strains have been applied for its successful overproduction by biotechnological processes, resulting in strains producing up to 71 g/L of SA, with high conversion yields of up to 0.42 (mol SA/mol Glc), in both batch and fed-batch cultures using complex fermentation broths, including glucose as a carbon source and yeast extract. Global transcriptomic analyses have been performed in SA-producing strains, resulting in the identification of possible key target genes for the design of a rational strain improvement strategy. Because possible target genes are involved in the transport, catabolism, and interconversion of different carbon sources and metabolic intermediates outside the central carbon metabolism and SA pathways, as genes involved in diverse cellular stress responses, the development of rational cellular strain improvement strategies based on omics data constitutes a challenging task to improve SA production in currently overproducing engineered strains. In this review, we discuss the main metabolic engineering strategies that have been applied for the development of efficient SA-producing strains, as the perspective of omics analysis has focused on further strain improvement for the production of this valuable aromatic intermediate. </div>
</front>
</TEI>
<affiliations><list><country><li>Mexique</li>
</country>
</list>
<tree><country name="Mexique"><noRegion><name sortKey="Martinez, Juan Andres" sort="Martinez, Juan Andres" uniqKey="Martinez J" first="Juan Andrés" last="Martínez">Juan Andrés Martínez</name>
</noRegion>
<name sortKey="Bolivar, Francisco" sort="Bolivar, Francisco" uniqKey="Bolivar F" first="Francisco" last="Bolívar">Francisco Bolívar</name>
<name sortKey="Escalante, Adelfo" sort="Escalante, Adelfo" uniqKey="Escalante A" first="Adelfo" last="Escalante">Adelfo Escalante</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000D06 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000D06 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= StressCovidV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:26442259 |texte= Shikimic Acid Production in Escherichia coli: From Classical Metabolic Engineering Strategies to Omics Applied to Improve Its Production. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:26442259" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a StressCovidV1
This area was generated with Dilib version V0.6.33. |